Skip to content
DataLookout
Menu

NCT07936058

A Phase I Study to Evaluate the Food Effect on Ecnoglutide Tablet

StatusNot Yet Recruiting
PhasePhase 1
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Maximum concentration
Timeframe: From Day1 to Day42
Minimum concentration
Timeframe: From Day1 to Day42
Area under the curve from time 0 to infinity
Timeframe: From Day1 to Day42
Area under the curve from time 0 to 24h
Timeframe: From Day1 to Day42
Area under the curve from time 0 to last quantifiable time point
Timeframe: From Day1 to Day42
Time to reach maximum concentration
Timeframe: From Day1 to Day42

Secondary (2)

The incidence of adverse events
Anti-drug antibody

Arms and interventions

F1Experimental

Day 1 to Day 14: Fast overnight for at least 10 hours before each dose, and take the tablet with 240 mL of plain water. No food intake is allowed within 4h after dose administration.

F2Experimental

Day 1 to Day 13: take breakfast within 30min before each dose, and then take the tablet with 240 mL of plain water. No food intake is allowed within 4h after dose administration. Day 14: take breakfast with high fat and high calorie

T1Experimental

Day 1 to Day 14: fast after 30min of dosing

T2Experimental

Day 1 to Day 14: fast after 60min of dosing

Drugs: Dose 1, Dose 2

Sites

1 site in 1 country

  • Zhejiang Provincial People's HospitalHangzhou, Zhejiang, China